Chemed (NYSE:CHE) reported quarterly earnings of $4.74 per share which beat the analyst consensus estimate of $4.65 by 1.94 percent. This is a 6.32 percent decrease over earnings of $5.06 per share from the same period last year.
Truist Securities Maintains Hold on Okta, Lowers Price Target to $70
Truist Securities analyst Joel Fishbein maintains Okta (NASDAQ:OKTA) with a Hold and lowers the price target from $100 to $70.